Lakewood, OH
Peptide Therapy clinics in Lakewood
Lakewood has a west Denver suburb with a mix of longtime residents and new arrivals, and peptide therapy has grown into a visible slice of the local wellness market. The clinics we track across Belmar, Green Mountain, and the Golden border range from physician-led longevity practices to medspa-adjacent wellness offices offering sermorelin blends and growth hormone peptides. Most local prescribers have training or admitting privileges within the St. Anthony and UCHealth Lutheran network. The scene here skews toward physician-led clinics serving a mixed-demographic west metro population. The regulatory landscape shifted sharply in 2023 and 2024 when the FDA placed several widely prescribed peptides on its Category 2 bulk substances list, restricting which ingredients compounding pharmacies could legally source. That changed access overnight for BPC-157, CJC-1295, ipamorelin, and thymosin beta-4. Sermorelin and tesamorelin remain FDA-approved for specific indications, and reputable Lakewood clinics now draw a clearer line between approved peptides and off-label research compounds than they did two years ago.
No clinics found
Reset all filtersRegulatory context
A note on Ohio's peptide therapy rules.
Most research peptides used in regenerative medicine (BPC-157, TB-500, CJC-1295, ipamorelin) are not FDA-approved drugs. Sermorelin and tesamorelin hold FDA approvals for specific indications. The FDA placed several peptides into Category 2 on its Bulk Drug Substances Nominated for Use in Compounding list during 2023 and 2024, restricting 503A pharmacy sourcing. Section 503A covers traditional patient-specific compounding; Section 503B covers FDA-registered outsourcing facilities held to cGMP.
-
Ohio Revised Code Chapter 4729 (Pharmacists, Dangerous Drug Distributors)
Governs pharmacy licensure and compounding under the Ohio State Board of Pharmacy. -
Ohio Revised Code Chapter 4731 (Physicians; Limited Practitioners)
Regulates physician prescribing and delegation. -
Ohio Administrative Code 4729:5-19 and 4729:5-20
Set non-sterile and sterile compounding standards, including USP 795 and 797 alignment.
The Ohio State Board of Pharmacy actively inspects compounding pharmacies and issues Dangerous Drug Distributor (TDDD) licenses to clinics that keep controlled or dangerous drugs on site. Non-resident pharmacies shipping peptides into Ohio must hold a current Ohio non-resident license. Ohio publishes disciplinary actions and enforcement orders, including against clinics that stock dangerous drugs without the required TDDD license.
Peptide Therapy in Lakewood, answered.
Explore related care